Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells 1,827 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 1,827 shares of the company’s stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $27.46, for a total transaction of $50,169.42. Following the completion of the sale, the chief financial officer now directly owns 103,591 shares of the company’s stock, valued at $2,844,608.86. This trade represents a 1.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total transaction of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total value of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Performance

Shares of Phreesia stock opened at $26.00 on Monday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The firm has a market capitalization of $1.53 billion, a P/E ratio of -17.69 and a beta of 1.03. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a fifty day simple moving average of $27.38 and a two-hundred day simple moving average of $24.19.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on PHR shares. Canaccord Genuity Group upped their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. Citigroup boosted their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Robert W. Baird reduced their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Finally, Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $31.33.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. grew its holdings in Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd bought a new stake in shares of Phreesia in the 4th quarter worth approximately $30,000. BankPlus Trust Department purchased a new stake in shares of Phreesia in the 4th quarter worth approximately $34,000. Quarry LP increased its position in Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after buying an additional 1,923 shares in the last quarter. Finally, Venturi Wealth Management LLC purchased a new position in Phreesia during the fourth quarter valued at $76,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.